BCI-215 is a small molecule that induces selective cytotoxicity in cancer cells. Its mechanism involves a non-redox activation of the MAPK signaling pathway. This compound is a useful research tool for investigating targeted cancer therapies in both in vitro and in vivo experimental models.
Molekulargewicht:
396.32
Reinheit:
99.81% (May vary between batches)
CAS Nummer:
[1245792-67-9]
Formel:
C22H22BrNO
Target-Kategorie:
Phosphatase
Anwendungsbeschreibung:
Solubility: DMSO:3.97 mg/mL (10.02 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten